Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups (Q35593869)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 2003

Language	Label	Description	Also known as
English	Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups	scientific article published on November 2003

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups (English)

1 reference

Europe PubMed Central

9 August 2017

hypercholesterolemia

0 references

HDL cholesterol

0 references

1 reference

based on heuristic

inferred from title

author name string

Michael H Davidson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Leiv Ose

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Jiri Frohlich

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Russell S Scott

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Carlos A Dujovne

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Ivan D Escobar

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Marcelo C Bertolami

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Frank Cihon

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Darbie L Maccubbin

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Michele Mercuri

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

publication date

1 November 2003

1 reference

Europe PubMed Central

9 August 2017

Clinical Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

509-514

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261106

21 January 2018

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261106

21 January 2018

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261106

21 January 2018

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome X: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-density lipoprotein, low-density lipoprotein and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value for coronary heart disease of baseline high-density and low-density lipoprotein cholesterol among Fredrickson type IIa subjects in the Helsinki Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14640465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.4960261106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653971&resulttype=core&format=json

15 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35593869&oldid=2098476610"